Koyfin Home > Directory > Health Care > Adma Biologics > Repurchase of Common Stock

Adma Biologics Repurchase of Common Stock Chart (ADMA)

Adma Biologics annual/quarterly Repurchase of Common Stock from 2012 to 2016.
  • Adma Biologics Repurchase of Common Stock for the quarter ending September 09, 2016 was $0m a 12.89% decrease of 0m year over year
  • Adma Biologics Repurchase of Common Stock for the last 12 months ending June 06, 2017 was $0m a 12.89% decrease of 0m year over year
Other Cash Flow Metrics:
  • Adma Biologics Cash Flow from Operations for the quarter ending December 12, 2018 was $-19m a 12.55% decrease of -2m year over year
  • Adma Biologics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-14m a 28.03% decrease of -4m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Repurchase of Common Stock Data

09/2016$0m
09/2015$0m
06/2015$0m
12/2012$0m

Annual ADMA Repurchase of Common Stock Data

2012$0m